The oral version of the weight-loss medication Wegovy has officially launched in the UAE, marking the country as the first market outside the United States to offer the pill. With prices ranging from Dh779 to Dh1,610 depending on the dosage, the medication is already seeing robust demand across major pharmacy chains and healthcare providers. While stock levels can vary by location, facilities like International Modern Hospital and Aster Pharmacy report steady interest, with some providers even managing extensive waiting lists to accommodate the influx of patients.

What makes this rollout particularly noteworthy is the shift in patient demographics; pharmacists are reporting a surge in inquiries from individuals who have never pursued medical weight-loss treatments before. Many patients appear to find the pill format significantly more approachable than traditional injectable options, effectively lowering the barrier to entry for those previously hesitant about weight management therapy. As awareness grows, healthcare providers anticipate that the convenience of an oral dose will continue to drive interest, with suppliers advising facilities to maintain consistent stock to keep pace with the evolving public demand.